Dr. Natalia Y. Kramarevsky, MD

Dr. Kramarevsky practices at New Ulm Medical Center in New Ulm, Minnesota, part of Sutter Health.

Dr. Kramarevsky's NPI, 1154368421, was assigned on June 2, 2006. Dr. Kramarevsky graduated from University of Washington School of Medicine in 1999. Dr. Kramarevsky holds Minnesota license 46026.

Dr. Kramarevsky's primary practice is New Ulm Medical Center, at 1324 Fifth North Street, New Ulm, MN 56073 in Brown County. The practice phone is (507) 217-5000.

Dr. Kramarevsky's primary practice is New Ulm Medical Center in New Ulm, Minnesota, part of Sutter Health. Dr. Kramarevsky is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Kramarevsky to 1 more hospital, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kramarevsky practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kramarevsky's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kramarevsky is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kramarevsky's licenses on file in 3 states: Minnesota, Virginia and Washington.

CMS data shows 2,341 Medicare services from Dr. Kramarevsky across 22 procedure codes in 2024, for 544 Medicare patients. Medicare paid $90,015 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 544 Medicare patients who saw Dr. Kramarevsky in 2024. The largest group is 75 to 84, with 212 patients. 73% of them have high blood pressure, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kramarevsky's median patient age at 75, with 56% women.

In 2024, Dr. Kramarevsky wrote 2,909 Medicare Part D claims for 473 patients. 74% of them were for generic drugs. CMS names the drug for 2,828 of them, across 23 drugs with 11 or more claims each, at $221,692 in total drug cost. In 2023, CMS named 2,826 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Kramarevsky for performance year 2024, reported as part of a group. Dr. Kramarevsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 81 procedures of cataract surgery by Dr. Kramarevsky, more than 71% of the clinicians it reports for that procedure.

CMS Open Payments shows 20 general payments to Dr. Kramarevsky from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Alcon Laboratories Inc paid the most, $778.

Dr. Kramarevsky graduated from University of Washington School of Medicine in 1999.